Creart
Creart Products are primarily used for
Female infertility, Prostate cancer
About Creart Products
Uses of Creart Products
Cetrorelix is used in the treatment of female infertility and prostate cancer.
Creart Products side effects
Common
Side Effects of Creart are Nausea, Ovarian hyperstimulation syndrome, Headache.
Severe
Side Effects of Creart are Local site reactions, Stillbirths, Ventricular septal defect, Bilateral congenital glaucoma, Congenital anomalies, Supernumerary nipple, Bilateral strabismus, Imperforate hymen, Congenital nevi, Hemangiomata, QT syndrome, Anencephaly at birth.
How Creart Products work
In females undergoing treatment for infertility, sometimes premature ovulation can lead to the release of eggs which are not ready for fertilisation. Cetrorelix blocks the action of a natural hormone and prevents premature release of the eggs from the ovary.
Patient Concerns about Creart Products
Frequently asked questions about Creart Products
Frequently asked questions about Cetrorelix
Q. What is Creart 0.25mg Injection and for what it is used for?
Creart 0.25mg Injection is an injectable preparation, which contains the active substance Ganirelix. It is used in women undergoing certain fertility treatments. It acts by blocking the release of luteinizing hormone (LH) thus preventing eggs from being released too early and gives the eggs time to grow properly. It is usually used in combination with other medicines.
Q. How and in what dose can it be used?
It is given as an injection, only at the hospital or clinic by the medical healthcare professional. The patient may be monitored regularly for the follicular development. The treatment duration depends on the ovarian response of the patient.
Q. What may be the possible side effects associated with it?
The most common side effect is local site reaction (redness of skin with or without swelling). You may also feel a headache or nausea. However, these effects are temporary, if these persist consult with your doctor. In addition, conditions like ovarian hyperstimulation syndrome (OHSS), and multiple births or birth defect, may also be associated with the use of this medicine.